The core function of the Screening Group (SCR) at IARC is to provide data on the accuracy, reproducibility, efficacy, benefits, harmful effects, and cost-effectiveness of various early detection interventions for breast, cervical, colorectal, and oral cancers, among others, in reducing deaths and improving patients’ quality of life in various settings. These data can then be used to inform and improve the rational use of health-care resources. The Group’s ultimate objective is to guide the development of public health policies for implementing screening in a variety of health-care settings, in particular in low- and middle-income countries (LMICs).
SCR conducts field studies in LMICs to evaluate various early detection methods for breast, cervical, colorectal, and oral cancer control. These initiatives also address the means by which screening services could be scaled up through local public health services. SCR develops various training resources to catalyse and augment capacity building in close collaboration with national institutions and government health services. Through its research programme, SCR generates scientific evidence to support the development of resource-appropriate early detection policies and health systems for the delivery of effective early services. The Cancer Screening in 5 Continents (CanScreen5) project of the Group aims to collect information on characteristics and performance of cancer screening programmes around the world and disseminate such information for informed decision making in cancer screening programmes. For example, the Group significantly contributed also to the evaluation of the safety and efficacy of less than three doses of the HPV vaccine in protecting against cervical cancer.
Meeting in RuiJin Hospital in Shanghai, China24/06/2019 – 25/06/2019
Dr Catherine Sauvaget met with Prof. Shusheng Wang, Director of Zhangjiagang Hospital and his team as well as with Prof. Weiwei Feng, Head of the Gynaecology Department of RuiJin Hospital in Shanghai to discuss future collaboration.
Meeting report: Promoting and embedding the European Code Against Cancer within Screening Programmes: Current status and future perspectives24/06/2019
On 6-7 May 2019, during the Romanian presidency of the Council of the EU, ECL, CPO Piemonte and IARC co-organised the first ECL Screening Workshop. Key stakeholders and experts from 11 EU countries were hosted by the Romanian Cancer Society and local partners to discuss how to embed the European Code Against Cancer within screening programmes. Read the Workshop Statement and consult the Meeting Report.
RuiJin Obstetrics and Gynecology International Academic Forum, Shanghai, China21/06/2019 – 23/06/2019
Dr Catherine Sauvaget introduced the work of IARC and Screening Group on cervical cancer control during this international academic forum.
|Vale D.B., Filho C.C., Shinzato J.Y., Spreafico F.S., Basu P., Zeferino L.C. Downstaging in opportunistic breast cancer screening in Brazil: a temporal trend analysis. BMC Cancer. 2019 May 10;19(1):432.|
|Mahajan M., Naik N., Jain K., Patira N., Prasad S., Mogri S., Muwonge R., Lucas E., Faruq F., Sankaranarayanan R., Iyer S., Basu P. Study of Knowledge, Attitudes, and Practices Toward Risk Factors and Early Detection of Noncommunicable Diseases Among Rural Women in India. J Glob Oncol. 2019 Apr;(5):1-10.|
|Vale D.B.,Sauvaget C., Murillo R., Muwonge R., Zeferino L.C., Sankaranarayanan R. Correlation of Cervical Cancer Mortality with Fertility, Access to Health Care and Socioeconomic Indicators. Rev Bras Ginecol Obstet. 2019 Mar 25.|